HS Code 30021230 โ Antisera for rabies
Chapter 30 (Pharmaceutical Products) ยท Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products) ยท Last updated: May 2026 ยท Source: Indian Customs (DGFT) Records
HS Code 30021230 (Antisera for rabies) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $5.6B across 570 shipments, this code covers 5 distinct pharmaceutical products exported by 23 Indian manufacturers to 37 countries. The leading product under this classification is Immunoglobulin at $5.6B, followed by Serum and Vaccine.
The top importing markets include Pakistan, Nigeria, Bangladesh. The top 5 products account for 100.0% of total trade under this code. Average transaction value is $9.9M. Leading exporters include GLAXOSMITHKLINE BIOLOGICALS SA and SANOFI PASTEUR. Data sourced from Indian Customs (DGFT) shipping bill records.

Products Exported Under HS Code 30021230
5 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Immunoglobulin | $5.6B | 87 | $5901.19 | 18 |
| #2 | Serum | $14.7M | 206 | $21.82 | 23 |
| #3 | Vaccine | $1.6M | 273 | $8.20 | 44 |
| #4 |